Showing 1321-1330 of 1560 results for "".
- Johnson & Johnson Vision Introduces Tecnis Synergy IOLhttps://modernod.com/news/johnson-johnson-vision-introduces-tecnis-synergy-iol/2476884/Johnson & Johnson Vision announced the availability of the Tecnis Synergy IOL for patients in Europe, Australia, and New Zealand. The Tecnis Synergy IOL creates a new standard in presbyopia-correcting IOL (PC-IOL) technology, allowing patients to experience continuous high-contrast vision fro
- Johnson & Johnson Vision to Launch Tecnis Synergy IOL and Showcase Latest Clinical Data at ESCRShttps://modernod.com/news/johnson-johnson-vision-showcases-latest-clinical-data-and-eye-care-solutions-at-escrs-2/2476873/Johnson & Johnson Vision will highlight key clinical data and the latest solutions in its growing portfolio of innovative products designed to improve vision care across generations at the upcoming European Society of Cataract and Refractive Surgeons (ESCRS) 2019 Annual Meeting in Paris, Fran
- Oklahoma Judge Orders Johnson & Johnson to Pay $572 Million in Bellwether Opioid Casehttps://modernod.com/news/oklahoma-judge-orders-johnson-johnson-to-pay-572-million-in-bellwether-opioid-case/2476824/A US judge has ruled that Johnson & Johnson must pay $572 million for contributing to an opioid crisis in Oklahoma, where the state’s attorney general had been seeking damages of more than $17 billion. District court Judge Thad Balkman said “the state met its burden that
- Johnson & Johnson Vision Launches New Surgical Vision Experience Center at the Johnson & Johnson Institute in Jacksonvillehttps://modernod.com/news/johnson-johnson-vision-launches-new-surgical-vision-experience-center-at-the-johnson-johnson-institute-in-jacksonville/2476784/Johnson & Johnson Vision announced today the launch of the Surgical Vision Experience Center at the Johnson & Johnson Institute in Jacksonville, Florida. The center will serve as Johnson & Johnson Vision’s premier physical t
- Johnson & Johnson Vision Highlights New Data on Personalized Vision Approach with Tecnis Family of IOLs and Highlights Progress of Innovative Pipeline at ASCRShttps://modernod.com/news/johnson-johnson-vision-highlights-new-data-on-personalized-vision-approach-with-tecnis-family-of-iols-and-highlights-progress-of-innovative-pipeline-at-ascrs/2476548/Johnson & Johnson Vision announced that a series of new data will be presented that further support advancements and innovations in the treatment of cataracts, dry eye, and laser vision correction. These analyses will be presented at the 2019 American Society of Cataract and Refractive Surger
- Johnson & Johnson Vision Showcases the Rising Burden of Myopia, New Contact Lens and Surgical Technologies at ARVOhttps://modernod.com/news/johnson-johnson-vision-showcases-the-rising-burden-of-myopia-new-contact-lens-and-surgical-technologies-at-arvo/2476549/Johnson & Johnson Vision showcased new research abstracts covering topics across a range of eye health needs at the Association for Research in Vision and Ophthalmology annual meeting (ARVO) in Vancouver, Canada, April 28-May 2, 2019. Presentations included the first predictive model for dire
- Johnson & Johnson Vision Announces Availability of Acuvue Oasys With Transitions Light Intelligent Technology in the U.S.https://modernod.com/news/johnson-johnson-vision-announces-availability-of-acuvue-oasys-with-transitions-light-intelligent-technology-in-the-u-s/2479584/Johnson & Johnson Vision announced the US availability of Acuvue Oasys with Transitions Light Intelligent Technology. The contact lenses adapt to changing light, helping eyes recover from bright light up to 5 seconds faster, reducing halos and starbursts at night, and delivering more sight w
- Johnson & Johnson Vision’s Investigational Antihistamine-Releasing Contact Lens Demonstrates Positive Phase 3 Resultshttps://modernod.com/news/johnson-johnson-visions-investigational-antihistamine-releasing-contact-lens-demonstrates-positive-phase-3-results/2476418/Johnson & Johnson Vision announced that results from two phase 3 clinical studies evaluating the company’s investigational antihistamine-releasing contact lens (etafilcon A with 0.019 mg ketotifen) were published in the journal Cornea. The results demonstrated that patients weari
- Johnson & Johnson Vision Announces Availability in Europe of Tecnis Eyhance IOLhttps://modernod.com/news/johnson-johnson-vision-announces-availability-in-europe-of-tecnis-eyhance-iol/2476332/Johnson & Johnson Vision announced the launch of its Tecnis Eyhance IOL in Europe. This next-generation monofocal IOL allows patients to experience high-quality vision at both intermediate and far distances. “With the availability of Tecnis Eyhance IOL in Europe, we are proud to deliv
- Johnson & Johnson Reports 2018 Fourth-Quarter Resultshttps://modernod.com/news/johnson-johnson-reports-2018-fourth-quarter-results/2476175/Johnson & Johnson announced sales of $20.4 billion for the fourth quarter of 2018, an increase of 1.0% as compared with the fourth quarter of 2017. Operational sales results increased 3.3%, and the negative impact of currency was 2.3%. Domestic sales increased 1.